FMT and Other Gut Microbial Therapies National Registry: Acute Severe and Fulminant C. Difficile Infection

Clinical Trial Details

This registry study is being done to collect information on fecal microbiota transplantation (FMT) and other gut microbial therapies (GMTs). Participants in this research study will have been given an FMT, or other GMT. FMTs and other GMTs are standard medical care used to treat patients who have recurrent Clostridioides difficile infection.
   
FMT is a medical procedure in which the stool from a healthy person (called a donor) is prepared and then put into the intestine of a sick patient. All stool is tested to ensure it is safe and healthy before being used in a sick patient. FMT is most commonly used to treat Clostridium difficile (C. diff ) infection, if antibiotics have not been able to get rid of the infection. Researchers are studying whether FMT may help treat other diseases.
   
Participants’ information (i.e. weight, demographic information, medical history, hospitalization) will be collected. They will be contacted every year for 10 years to fill out a short online survey regarding their health and how they’re feeling. The FMT Registry hopes to fill in the gaps of what we don’t know about FMT. We hope this registry may help give participants a safe space to give feedback on how they feel after getting the procedure. In addition, participants have the option of partaking in an optional sub-study. Participants will need to provide a stool sample that will be stored (banking) in a freezer.

Key Eligibility: 
  1. Men and women who are 18 years of age and older.
  2. Receiving FMT or other gut-related microbiota product within 90 days after providing consent or providing stool sample for FMT.

Detailed eligibility will be reviewed when contacting the study team.
   

Study contact by location

Upper East Side - Manhattan

Contact(s)

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

2501028470

Status

Open to Enrollment

Age Group

Adult

Sponsor